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ABSTRACT 
The aim of the present research is to formulate a sublingual tablet of antiemetic drug. Doxylamine succinate is an antihistaminic 
commonly used for the prevention and treatment of nausea and vomiting. Oral bioavailability of doxylamine succinate is low and 
shows extensive hepatic metabolism. The Objective of the present research is to formulate doxylamine succinate sublingual tablet to 
avoid hepatic first pass metabolism and to improve its bioavailability. Sublingual route not only overcome the problem of dysphagia 
but also giving the rapid onset of action by enhancing permeability through site of administration 
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INTRODUCTION 
In terms of permeability, the sublingual area of the oral 
cavity (i.e. the floor of the mouth) is quite successful 
than the buccal (cheek) area, which in turn is more 
permeable than the palatal (roof of the mouth) area. The 
absorption potential of oral mucosa is influenced by the 
Passive diffusion involves the movement of a drug from 
the region of higher concentration to the region of lower 
concentration across biological membrane Systemic drug 
delivery through the sublingual route had emerged from 
the desire to provide immediate onset of pharmacological 
effect.
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The sublingual tablets are usually small, flat and 
compressed lightly to keep them soft. These tablets are 
designed in such a way that they must dissolve quickly in 
small quantity of saliva and allow the drug to be 
absorbed through the sublingual mucosa. The various 
types of sublingual tablets commonly used are Fast 
disintegrating sublingual tablets, Bio adhesive sublingual 
tablets and Lipid matrix sublingual tablets.
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Doxylamine succinate N-dimethyl-2-(1-phenyl-1-
pyridin-2-ylethoxy)ethanamine is a first generation 
antihistamine that is used for symptoms of allergic 
rhinitis, common cold and as a short acting sedative. The 
drug has activity and absorbed orally only 24.7% due to 
hepatic metabolism with peak plasma concentrations 
achieved in 6-12 hours following oral administration of 
therapeutic doses. 
MATERIAL AND METHODS  
Materials 
Doxylamine succinate was a gift sample obtained from 
Microlabs, Mumbai. Sodium Starch Glycolate, 
Microcrystalline cellulose, Mannitol, Sodium saccharine, 
Magnesium stearate, Talc, Isopropyl alcohol were 
purchased from Kasliwal Brothers, Indore. Kyron-134 
was obtained as gift sample from Coral-pharmachem, 
Ahmadabad. All chemicals were used of analytical 
grade. 
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Methods 
Analytical Methods 
Melting point determination 
Capillary tube was taken and one end was sealed by 
heating. Capillary tube was filled with drug powder up to 
2-3mm high. The capillary tube was putted inside 
melting point apparatus and temperature was increased 
slowly. The temperature was noted when the drug gets 
starts melting and again noted when drugs completely 
melted. 
UV Spectroscopy 
50mg of Doxylamine succinate was weighed and 
dissolved into 50ml of distilled water to prepare a 
1000µg/ml stock solution from which a 10µg/ml dilution 
was prepared. Baseline correction was performed using 
distilled water and sample was run between 200-400nm 
wavelength range in spectrum mode. 
Calibration curve  
The calibration curve of Doxylamine succinate were 
prepared in distilled water and 6.8 pH phosphate buffer 
by using Shimadzu 1800 UV visible spectrophotometer. 
Accurately weighed 50mg of Doxylamine succinate was 
transferred into a 50ml volumetric flask and the volume 
was made up with distilled water to obtain a 1000µg/ml 
stock solution of Doxylamine succinate. 
 
Figure 1: Lambda Max of Doxylamine succinate 
 
Figure 2: Calibration curve of Doxylamine succinate 
From the stock solution 1ml was taken and transferred 
into a 10ml volumetric flask and rest of the volume was 
made up with methanol to obtain a 100µg/ml of solution 
from which 1 to 10µg/ml dilutions were prepared. Same 
procedure was followed for distilled water to prepare 
calibration curve respectively. 
3
 
Solubility studies 
The solubility of Doxylamine succinate in various 
medium was determined by shake flask method. In this 
method 2ml of each solvent was taken into a vial and an 
excess amount of Doxylamine succinate was added. The 
vials were sealed properly and stirred for 10min. They 
were then kept on orbital flask shaker at 37°C for 24h. 
After solubilization of Doxylamine succinate, an extra 
amount of Doxylamine succinate was added to the vials 
containing drug-solvent mixture. The process was 
repeated until saturation solubility of Doxylamine 
succinate, indicated by presence of undissolved drug. 
The mixtures were then kept at room temperature for 24 
h. and centrifuged using Remi12C micro-centrifuge at 
3000RPM for 15min. The supernatant were separated 
and diluted with respective solvents. The drug 
concentration was analyzed spectrophotometrically at 
262 nm using UV-visible spectrophotometer (Shimadzu-
1800).
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Formulation 
Taste Masking 
Doxylamine succinate and Kyron 134 was taken in 1:5 
ratios for taste masking. Kyron 134 was added to 25ml of 
distilled water in a beaker. The mixture was stirred for 
half an hour. Doxylamine succinate was added to it and 
the mixture was stirred for 2 hours at 1000 rpm. The 
complex was filtered using Whatman filter paper. The 
above mixture was dried. 
Experimental design 
A central composite design for two factor three level was 
selected to optimize the variable response. The two 
factors, viz. Polymer X1 Kyron-134 and Polymer X2 
Sodium Starch glycolate of each polymer blend, were 
required by the experimental design and the factor level 
were suitably coded. The amount of Magnesium stearate, 
Talc, Sodium Saccharine and mannitol was kept 
constant, while Microcrystalline cellulose was taken in a 
sufficient quantity to maintain a constant tablet mass of 
120mg. time taken to release 90% of drug were taken as 
the variable response. 
 
Table 1: Composition of various formulations of tablets 
S.no. Ingredients F1 F2 F3 F4 F5 F6 F7 F8 F9 
1. Doxylamine succinate 50 50 50 60 60 60 70 70 70 
2. Sodium starch glycolate 52.5 42.5 32.5 42.5 32.5 22.5 32.5 22.5 11.5 
3. Microcrystalline cellulose 10 20 30 10 20 30 10 20 30 
4. Mannitol 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 
5. Sodium saccharine 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 
6. Magnesium stearate 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 
7. Talc 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 
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Precompression evaluation (Drug excipients mixture) 
Bulk density 
Bulk density is defined as the ratio of mass of the 
powder to the bulk volume of the powder. 10gm of 
powder were taken in a 100ml measuring cylinder and 
noted down the volume occupied by the powder. 
Tapped density 
Tapped density is defined as the ratio of the mass of the 
bulk powder to the tapped volume of the powder. 10gm 
of powder were taken in a100ml measuring cylinder and 
noted down the volume occupied by the powder after 
tapping. 
Angle of repose 
Angle of repose is a characteristic related to inter-
particulate friction. The angle of repose was performed 
to determine the flow property of the formed powder. 
Set the funnel 4cm above the working slab. Pour the 
powder through funnel until pile of powder touches the 
funnel. Note the height and diameter/radius of the pile of 
powder. Determine angle of repose by applying the 
formula. 
tanθ = h/r 
where θ = angle of repose 
 h = height of pile 
 r = radius of pile 
Hausner’s ratio 
Flow ability of a powder was evaluated by comparing 
the bulk density and tapped density of a powder. It is an 
indication of compressibility of a powder. It measures 
the relative significance of interparticle interactions. A 
Hausner’s ratio of ˂1.25 indicates a powder that is free 
flowing whereas >1.25 indicates poor flow ability of 
powder. 
20gm powder was taken in measuring cylinder. Note the 
poured volume of powder. Now it was tapped for 100 
times. Tapped volume of powder was noted. Poured 
density and tapped density by applying the formula was 
determined. 
Poured density = 
              
                       
 
Tapped density = 
              
                       
 
 
Determine Hausner’s ratio and Carr’s Index 
Hausner’s ratio = 
               
            
 
Preparation of Doxylamine succinate Sublingual 
tablet by direct compression method 
 Weigh all Ingredients as per the quantities defined in 
table no. 1 
 Pass all the ingredients through sieve #80 and collect 
individuals in polybags. 
 Mix measured quantity of Doxylamine Succinate and 
kyron 134, sodium starch glycolate, MCC, Mannitol 
and Sodium Saccharine for 15 minutes in a polybag. 
 Magnesium stearate and talc was added to it and blend 
for 5 min in pastle mortar. 
 Compress final blend using B-Tooling, multiple 
rotatory compression machine using 6 mm round 
shaped punches and corresponding dies. 
Evaluation of Tablet 
Weight variation 
Weighed individually 20 tablets selected at random. 
Calculate the average weight. Not more than two of the 
individual weights deviate from the average weight by 
more than percentage shown in the table and none 
deviates by more than twice that percentage. If more 
than two tablets deviate from the range, retest 20 tablets 
are done and not more than 2 tablets should deviate from 
40 tablets. 
Thickness 
Set scale to zero. Place the tablet laterally between the 
jaws of vernier caliper. Make sure jaws shall just touch 
object to be measured. Record the reading displayed. 
Take out the sample, clean the jaws and keep the caliper 
in place. 
Hardness 
Place the tablet on the holder. Set the “0” on monsento 
tester scale. Press the tablet. The range of monsento 
hardness tester is “0 to 20” kg. When tablet breaks read 
the pressure applied and cleans the holder. 
Friability 
Connect the main socket. Weigh the tablets before 
placing it in friability apparatus. Place 10 tablets in the 
friability test apparatus. Switch “ON” the mains. Take 
out tablets after 100 revolutions has completed. Reweigh 
the tablets after dedusting. Switch “OFF” the mains. 
Clean the friability test apparatus. 
Wetting time 
The tablet was placed at the center of two layers of 
absorbent paper fitted into a petridish. After the paper 
was thoroughly wetted with distilled water, excess water 
was completely drained out of the dish. The time 
required for the water to diffuse from the wetted 
absorbent paper throughout the entire tablet was then 
recorded using a stopwatch. The evaluation parameters 
of batches F1 – F9 are shown in table. 
Water absorption ratio 
A piece of tissue paper folded twice was placed in a 
small petri dish containing 6 ml of water. A tablet was 
put on the tissue paper and allowed to completely wet. 
The wetted tablet was the reweighed. Water absorption 
ratio, R was determined using following equation 
R = 100 × Wa-Wb/Wa 
Where, Wa = Weight of tablet after water absorption 
Wb = Weight of wetted tablet before water absorption  
Disintegration Time 
One tablet was introduced into each tube and disc was 
added to each tube. The assembly was introduced in the 
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beaker containing purified water. The apparatus operated 
until the tablet completely disintegrate. The time was 
noted down until the tablets completely disintegrate 
without any remitants. The assembly was removed from 
water. 
In vitro Dissolution  
Switch ON the mains from electric board. 
Adjust/maintain temperature from heater knob. Maintain 
the water level in the water bath up to the specific mark. 
Place 900 ml of buffer in dissolution vessel and adjust 
temperature between 36.5-37.5 ᴼC. Shaft is positioned in 
such a way that its axis is within 2 mm of axis of the 
vessel and lower edge of blade is 23-27 mm from the 
inside of bottom of vessel. Lower down the paddle in the 
vessel. Put on tablet in the vessel. Immediately ON the 
apparatus at 50 rpm for 30 min. Withdraw 5 ml sample 
at every 5 minutes interval and replace by volume of 
dissolution medium equal to the volume of sample 
removed. Filter the samples using whattman filter paper. 
Prepare appropriate dilutions and analyze the samples 
with UV spectrophotometer at λmax 262 nm. Determine 
the concentration and percentage drug release. Switch 
OFF heater and main of the apparatus.  
Stability studies 
The stability studies were carried out for a period of 1 
month in the stability chamber. The tablets were stored 
under the following conditions as prescribed by the ICH 
guidelines (40°C±2°C and 75±5% RH Q1C). The tablets 
were withdrawn periodically with an interval of 30 days 
and analyzed for Hardness, Disintegration, Dissolution, 
Wetting time, drug content etc. 
RESULT AND DISCUSSION 
Doxylamine succinate sublingual tablet was formulated. 
Total nine batches were prepared for sublingual 
formulation. All the formulations were subjected to 
evaluation, Tablet weight varied from 110 to 120 mg, 
and thickness 3 to 4.1 mm. Tapped density of 
formulation F2 was highest among the all formulations. 
All the tablets exhibited friability values between 0.5 to 
0.8. Tablets from Formulation F2 have shown lowest 
friability among the all formulations. All tablets 
disintegrated in less than 1 minute. The drug released at 
the time interval of 30 minutes up to 97.5% of batch F9. 
Initial release rate was found slow in case of formulation 
F1 & F2 as compared to other formulations. 
  
Table 2: Evaluation of Flow properties of powder (Drug excipient mixture) 
Characterization F1 F2 F3 F4 F5 F6 F7 F8 F9 
Bulk density 0.100 0.100 0.95 0.100 0.095 0.100 0.105 0.100 0.100 
Tapped density 0.117 0.125 0.117 0.111 0.117 0.125 0.117 0.111 0.117 
Carr’s index 14.25 20.00 18.80 9.90 18.80 20.00 10.25 9.90 14.52 
Hausner’s ratio 0.17 1.25 1.23 1.11 1.23 1.25 1.11 1.11 1.17 
Angle of repose 27.92 26.56 28.36 27.92 26.10 28.81 27.02 27.02 29.68 
 
Table 3: Determination of physicochemical properties of sublingual tablet 
Batch 
 
Hardness (Kg/cm
2
) ±SD Thickness (mm) ±SD Percent Friability (%)±SD Weight variation (mg) ±SD 
F1 2.833±0.057 3.9±0.199 0.853±0.0057 118.33±2.081 
F2 2.9±0.00 3.73±0.057 0.776±0.0152 114.33±0.577 
F3 2.76±0.057 3.83±0.115 0.823±0.0115 116.33±1.527 
F4 2.86±0.115 3.76±0.115 0.846±0.0057 114.66±2.081 
F5 3.16±0.057 3.93±0.115 0.783±0.0115 117.66±1.154 
F6 2.833±0.057 3.7±0.099 0.580±0.010 113±3.00 
F7 3.03±0.057 3.96±0.152 0.686±0.0057 117.33±0.577 
F8 2.86±0.057 3.93±0.0.57 0.826±0.0251 117.33±1.527 
F9 3.16±0.057 4.03±0.057 0.686±0.0057 119.33±0.577 
 
Table 4: Other Evaluation parameters 
Batch Drug Content Uniformity Wetting Time(Sec.) Water Absorption ratio Disintegration Time(Sec.) 
F1 93.33±2.516 24.33±4.041 51±2.645 106±6.92 
F2 89.66±0.5773 22±3.605 49.33±0.577 56.66±3.214 
F3 93.66±3.785 22.33±1.527 44.66±4.163 69.66±1.527 
F4 96±3.6055 26±4.582 42±3 65±3 
F5 98.33±0.5773 18.66±0.577 40±1 53.66±2.309 
F6 95±2.645 22.33±2.516 42.33±2.309 53±3.605 
F7 98.33±0.5773 18.66±1.527 35±3.605 54.33±4.041 
F8 93.66±4.041 22±2.645 36.66±2.516 53±4.582 
F9 98.66±0.577 17.66±0.577 32.66±0.577 48.33±0.577 
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Figure 2: In-vitro drug release of sublingual tablet 
Table 5: Stability studies 
S.No. Parameter After 30 days Inference 
1. Weight variation 119.33±0.574 Within Limit 
2. Hardness 3.16±0.055 Within Limit 
3. Drug content 98.66±0.578 Within Limit 
4. Wetting time 17.66±0.574 Within Limit 
5. Water absorption ratio 32.66±0.576 Within Limit 
6. Disintegration 48.33±0.575 Within Limit 
 
CONCLUSION 
The present study was carried out to prove that 
sublingual tablet of Doxylamine succinate can be 
formulated. The concept explains that formulated 
doxylamine succinate sublingual tablet avoids hepatic 
first pass metabolism and improves its bioavailability.  
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